2013 annual financial data
TG Therapeutics 2013 Net margin
Direct answer
Net margin was -13,438.82%.
Operating income was -22,965,989 USD and net income was -20,478,210 USD.
Operating cash flow was -10,824,231 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,381 USD
- Operating income
- -22,965,989 USD
- Net income
- -20,478,210 USD
- Operating cash flow
- -10,824,231 USD